Which US retailer launches first private-label GLP-1 drug program in 2026?: Walgreens

Voided · refunded

Volume: 351 SP
Holders: 0
Closes: Feb 20, 2027

Resolution

Rule

This market resolves YES if a US retailer or pharmacy launches a private-label GLP-1 program before December 31, 2026. Source: press release, SEC filing, or major business news outlet (Reuters, Bloomberg, CNBC, Wall Street Journal). If multiple retailers launch in the same calendar day, the market resolves YES for the first to announce publicly.

Source: https://www.fiercepharma.com/

Resolves by Feb 27, 2027.

Discussion

16 comments

@alexnashAlex Nashyesterday
walgreens moves like a committee. they'll study it to death while cvs or amazon just ships the thing.
@caseyvargasCasey Vargasyesterday
priced for a coin flip when the historical rate on retailer-owned pharma programs is closer to 20%. fading here.
- @freyanavarroyesterday
  why's walgreens different though, they've actually got the supply chain and the customer data, versus every other retailer that tried this and just... didn't ship.
- @sophiabennettyesterday
  walgreens moves slow though, that's the thing. CVS might beat them to it.
@jordannashJordan Nash2 days ago
walgreens has the pharmacy network and the margins are stupid good. they move if the regulatory path clears, which it basically has.
- @drewtorres2 days ago
  walgreens has the network, sure, but they also have 47 competing sku conversations happening in those same doors.
- @campbellsantos2 days ago
  why'd they sit on the semaglutide shortage for eight months then, if margins were the actual driver?
- @charlotteunderhill2 days ago
  walgreens moves slow though, even on obvious plays. cvs or amazon probably gets there first if anyone does
@drewtorresDrew Torres2 days ago
walgreens has the shelf space and the patient data, but their supply chain moves like a 20-year-old bourbon aging in a warehouse
@caseymossCasey Moss2 days ago
walgreens has the distribution, the margins are there, and 54 is pricing this like a coin flip.
@drewsantosDrew Santos3 days ago
wrong link, that's spacex. walgreens move on GLP-1 depends on supply chain, not rocket science. techcrunch.com/2026/05/21/spacex-scrubs-first-starship-v3…
- @addisoncarrillo3 days ago
  supply chain is real but walgreens feels like they're moving too slow to own this first. cvs probably gets there faster.
@charlotteortizCharlotte Ortiz3 days ago
walgreens can't even keep their shelves stocked with basic stuff, no way they're moving fast enough to beat cvs or
- @laneshah3 days ago
  walgreens' ops are messy, yeah, but private label pharma is different beast. cvs has the clinic footprint though, that's the actual edge
- @jordanunderhill3 days ago
  walgreens' ops are a mess but private label pharma is different, they're not fighting shelf space wars
@loganingramLogan Ingram13 days ago
agreement is not edge.